help button home button Endocrine Society Endocrine Reviews
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ferrara, N.
Right arrow Articles by Davis-Smyth, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ferrara, N.
Right arrow Articles by Davis-Smyth, T.
Endocrine Reviews 18 (1): 4-25
Copyright © 1997 by The Endocrine Society

The Biology of Vascular Endothelial Growth Factor

Napoleone Ferrara and Terri Davis-Smyth

Department of Cardiovascular Research, Genentech, Inc., South San Francisco, California 94080

I. Introduction
II. Biological Activities of VEGF
III. Organization of the VEGF Gene
IV. Properties of the VEGF Isoforms
V. Regulation of VEGF Gene Expression
A. Hypoxia
B. Cytokines
C. Differentiation and transformation
VI. The VEGF Receptors
A. Characterization and distribution of VEGF-binding sites
B. The Flt-1 and Flk-1/KDR tyrosine kinases
1. Binding characteristics
2. Signal transduction
3. Regulation
4. Structural requirements for ligand binding in Flt-1 and Flk-1/KDR
5. VEGF determinants for binding Flt-1 and Flk-1/KDR
VII. VEGF-Related Molecules
VIII. Role of VEGF and Its Receptors in Physiological Angiogenesis
A. Distribution of VEGF, Flk-1/KDR and Flt-1 mRNA
B. Analysis of Flk-1/KDR, Flt-1 and VEGF gene knockouts
IX. Role of VEGF in Pathological Angiogenesis
A. Tumor angiogenesis
1. Expression of VEGF in human tumors
2. Inhibition of VEGF action in vivo
B. Intraocular neovascular syndromes
C. Other pathological conditions
X. Therapeutic Applications of VEGF-Induced Angiogenesis
XI. Perspectives







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1997 by The Endocrine Society